BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E, Athanasiou A, Moris D, Sakellariou S, Kykalos S, Tsourouflis G, Garmpi A, Delladetsima I, Kontzoglou K, Kouraklis G. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol 2017; 23(29): 5282-5294 [PMID: 28839428 DOI: 10.3748/wjg.v23.i29.5282]
URL: https://www.wjgnet.com/1948-5204/full/v23/i29/5282.htm
Number Citing Articles
1
Ezio Lanza, Chiara Masetti, Gaia Messana, Riccardo Muglia, Nicola Pugliese, Roberto Ceriani, Ana Lleo de Nalda, Lorenza Rimassa, Guido Torzilli, Dario Poretti, Felice D’Antuono, Letterio Salvatore Politi, Vittorio Pedicini, Alessio Aghemo, Gianfranco D. Alpini. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinomaPLOS ONE 2020; 15(6): e0232371 doi: 10.1371/journal.pone.0232371
2
Tommaso Vincenzo Bartolotta, Adele Taibbi, Massimo Midiri, Roberto Lagalla. Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?Ultrasonography 2019; 38(3): 200 doi: 10.14366/usg.18060
3
Mengxue He, Ling Yu, Yuanyuan Yang, Binhua Zou, Wen Ma, Meng Yu, Jiandong Lu, Guoliang Xiong, Zhiqiang Yu, Aimin Li. Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts modelsChinese Chemical Letters 2020; 31(12): 3178 doi: 10.1016/j.cclet.2020.05.034
4
Yongxian Cao, Feng Zhang, Haotian Wang, Chunhua Bi, Jinpeng Cui, Fenghai Liu, Huazheng Pan. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axisMolecular and Cellular Biochemistry 2021; 476(1): 279 doi: 10.1007/s11010-020-03904-6
5
Jesús Rafael Rodríguez-Aguilera, Rebeca Pérez-Cabeza de Vaca, Nuria Guerrero-Celis, Gabriela Velasco-Loyden, Mariana Domínguez-López, Félix Recillas-Targa, Victoria Chagoya de Sánchez. Liver Cirrhosis - Debates and Current Challenges2019;  doi: 10.5772/intechopen.83481
6
Yang Li, An Jiang. ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6Cancer Biology & Therapy 2020; 21(7): 647 doi: 10.1080/15384047.2020.1743150
7
Peng-Sheng Yi, Chen-Jun Hu, Chen-Hui Li, Fei Yu. Clinical value of artificial intelligence in hepatocellular carcinoma: Current status and prospectArtificial Intelligence in Gastroenterology 2021; 2(2): 42-55 doi: 10.35712/aig.v2.i2.42
8
Yunxi Liu, Yue Chen, Weidong Fei, Caihong Zheng, Yongquan Zheng, Miao Tang, Ying Qian, Xiao Zhang, Mengdan Zhao, Meng Zhang, Fengmei Wang. Silica-Based Nanoframeworks Involved Hepatocellular Carcinoma TheranosticFrontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.733792
9
Bart Vanderborght, Kevin De Muynck, Sander Lefere, Anja Geerts, Helena Degroote, Xavier Verhelst, Hans Van Vlierberghe, Lindsey Devisscher. Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse modelOncotarget 2020; 11(48): 4504 doi: 10.18632/oncotarget.27830
10
Aimei Liu, Qinghua Wu, Dapeng Peng, Irma Ares, Arturo Anadón, Bernardo Lopez‐Torres, María‐Rosa Martínez‐Larrañaga, Xu Wang, María‐Aránzazu Martínez. A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylationMedicinal Research Reviews 2020; 40(5): 1973 doi: 10.1002/med.21696
11
Ludovico Abenavoli, Angelo A. Izzo, Natasa Milić, Carla Cicala, Antonello Santini, Raffaele Capasso. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseasesPhytotherapy Research 2018; 32(11): 2202 doi: 10.1002/ptr.6171
12
Mohamed Fawzi Kabil, Maha Nasr, Ibrahim M. El-Sherbiny. Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated reviewEuropean Journal of Pharmaceutics and Biopharmaceutics 2021; 167: 9 doi: 10.1016/j.ejpb.2021.07.003
13
Areeg M. Dabbish, Hana M. Abdelzaher, Moustafa Abohawya, Samir Shamma, Yosra H. Mahmoud, Amr Maged, Mohamed Manaa, Mohamed Hassany, Firas Kobeissy, Omid Bazgir, Hassan El-Fawal, Hassan M. E. Azzazy, Anwar Abdelnaser. Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical ValidationCancers 2022; 14(13): 3036 doi: 10.3390/cancers14133036
14
D. V. Sidorov, M. V. Lozhkin, L. O. Petrov, A. G. Isaeva, M. S. Gusakova. Combined extensive liver resections in patients with locally advanced hepatocellular cancer – clinical casesResearch and Practical Medicine Journal 2020; 7(2): 154 doi: 10.17709/2409-2231-2020-7-2-14
15
Wafaa M. Rashed, Mohamed Ahmed Mohamed Kandeil, Mohamed O. Mahmoud, Sameera Ezzat. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overviewJournal of the Egyptian National Cancer Institute 2020; 32(1) doi: 10.1186/s43046-020-0016-x
16
Indranil Banerjee, Paul B. Fisher, Devanand Sarkar. Advances in Cancer Research 2021; 152: 329 doi: 10.1016/bs.acr.2021.05.003
17
Ibrahim G Alghamdi, Mohamed S Alghamdi. <p>The Incidence Rate of Liver Cancer in Saudi Arabia: An Observational Descriptive Epidemiological Analysis of Data from the Saudi Cancer Registry (2004–2014)</p>Cancer Management and Research 2020; : 1101 doi: 10.2147/CMAR.S232600
18
Ismail Essadi, Issam Lalya, Mohamed Kaakoua, Adil Arsalane, Abdelhamid Elomrani, Mouna Khouchani, Rhizlane Belbaraka. Skull metastases revealing a hepatocellular carcinoma: Case report and literature reviewPrecision Medical Sciences 2020; 9(2): 94 doi: 10.1002/prm2.12011
19
Otilia Mårdh, Chantal Quinten, Andrew J. Amato-Gauci, Erika Duffell. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA – descriptive analysis and estimation of 2015 baselineInfectious Diseases 2020; 52(9): 625 doi: 10.1080/23744235.2020.1766104
20
Patrizia Leone, Antonio Giovanni Solimando, Rossella Fasano, Antonella Argentiero, Eleonora Malerba, Alessio Buonavoglia, Luigi Giovanni Lupo, Valli De Re, Nicola Silvestris, Vito Racanelli. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma TreatmentVaccines 2021; 9(5): 532 doi: 10.3390/vaccines9050532
21
Asmaa M. Zahran, Hanaa Nafady-Hego, Shima G. Mansor, Wael A. Abbas, Mohamed O. Abdel-Malek, Mohamed A. Mekky, Helal F. Hetta. Increased frequency and FOXP3 expression of human CD8+CD25High+ T lymphocytes and its relation to CD4 regulatory T cells in patients with hepatocellular carcinomaHuman Immunology 2019; 80(7): 510 doi: 10.1016/j.humimm.2019.03.014
22
Dow-Mu Koh, Ahmed Ba-Ssalamah, Giuseppe Brancatelli, Ghaneh Fananapazir, M. Isabel Fiel, Satoshi Goshima, Sheng-Hong Ju, Nikolaos Kartalis, Masatoshi Kudo, Jeong Min Lee, Takamichi Murakami, Max Seidensticker, Claude B. Sirlin, Cher Heng Tan, Jin Wang, Jeong Hee Yoon, Mengsu Zeng, Jian Zhou, Bachir Taouli. Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imagingEuropean Radiology 2021; 31(8): 5615 doi: 10.1007/s00330-020-07637-4
23
Anh Le Tuan Nguyen, Hoa Thi Thu Nguyen, Kwang Chien Yee, Andrew J. Palmer, Christopher Leigh Blizzard, Barbara de Graaff. A Systematic Review and Narrative Synthesis of Health Economic Evaluations of Hepatocellular Carcinoma Screening StrategiesValue in Health 2021; 24(5): 733 doi: 10.1016/j.jval.2020.11.014
24
Umakant Prasad, Deepak Kumar, Rashmi Rani Bharti, Sanjay Kumar Suman, Aishwerya Singh, Ravikant Kumar. Typical and Atypical Imaging Findings of Hepatocellular Carcinoma on Multiphasic MDCT Scan in Histologically Proved CasesJournal of Gastrointestinal and Abdominal Radiology 2022;  doi: 10.1055/s-0042-1742771
25
Jiejun Hu, Dong Cai, Zhibo Zhao, Guo-Chao Zhong, Jianping Gong. Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling PathwayFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.659676
26
Manali Dimri, Ande Satyanarayana. Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular CarcinomaCancers 2020; 12(2): 491 doi: 10.3390/cancers12020491
27
Christos Damaskos, Nikolaos Garmpis, Dimitrios Dimitroulis, Anna Garmpi, Evangelos Diamantis, Panagiotis Sarantis, Vasiliki E. Georgakopoulou, Alexandros Patsouras, Markos Despotidis, Dionysios Prevezanos, Athanasios Syllaios, Georgios Marinos, Evangelos Koustas, Christos Vallilas, Efstathios A. Antoniou, Konstantinos Kontzoglou, Spyridon Savvanis, Gregory Kouraklis. The Role of SNHG15 in the Pathogenesis of Hepatocellular CarcinomaJournal of Personalized Medicine 2022; 12(5): 753 doi: 10.3390/jpm12050753
28
Yan-Qiong Zhang, Yan Shen, Ming-Mei Liao, Xia Mao, Gu-Jie Mi, Chen You, Qiu-Yan Guo, Wei-Jie Li, Xiao-Yue Wang, Na Lin, Thomas J. Webster. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanismsNanomedicine: Nanotechnology, Biology and Medicine 2019; 15(1): 86 doi: 10.1016/j.nano.2018.09.002
29
Suchandrima Ghosh, Sayantani Bhowmik, Swagata Majumdar, Avijit Goswami, Joyeeta Chakraborty, Subash Gupta, Shaleen Aggarwal, Sukanta Ray, Raghunath Chatterjee, Suvendranath Bhattacharyya, Moumita Dutta, Simanti Datta, Abhijit Chowdhury, Gopal Krishna Dhali, Soma Banerjee. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha‐fetoprotein International Journal of Cancer 2020; 147(10): 2934 doi: 10.1002/ijc.33111
30
Justin K. H. Liu, Andrew F. Irvine, Rebecca L. Jones, Adel Samson. Immunotherapies for hepatocellular carcinomaCancer Medicine 2022; 11(3): 571 doi: 10.1002/cam4.4468
31
Anita Alizadeh, Asiyeh Jebelli, Behzad Baradaran, Mohammad Amini, Fatemeh Oroojalian, Mahmoud Hashemzaei, Ahad Mokhtarzadeh, Michael R Hamblin. Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancersGene 2021; 769: 145224 doi: 10.1016/j.gene.2020.145224
32
Yue Liu, Huasong Xia, Meng Li, Yuxin Chen, Wei Zhou, Yi Chen, Yanqing Wu, Liaqat Ali. Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular CarcinomaJournal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/3522866
33
Yi-Hsuan Hung, Yu-Chuan Lin, Yu-Ting Lin, Guan-Wen Shih, Jiunn-Wang Liao, Kuan-Sheng Chen, Hong-Ming Liu, Yi-Wei Chen, Yung-Jen Chuang, Chia-Min Yang, Jinn-Jer Peir, Chin-Hua Yang, Fong-In Chou. Suitability of boric acid as a boron drug for boron neutron capture therapy for hepatomaApplied Radiation and Isotopes 2020; 164: 109254 doi: 10.1016/j.apradiso.2020.109254
34
Zhiying Shao, Xin Liu, Chanjuan Peng, Liping Wang, Dong Xu. Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a reviewWorld Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02401-4
35
Chunhou Qi, Hongfei Gao, Qinghua Zhao, Lei Zhang. <p>Computed Tomography-Guided Percutaneous Cryoablation for ‎ Subcardiac Hepatocellular Carcinoma: Safety, Efficacy, Therapeutic Results and Risk Factors for Survival Outcomes</p>Cancer Management and Research 2020; : 3333 doi: 10.2147/CMAR.S250652
36
Josef Madrigal, Joseph Hadaya, Cory Lee, Zachary Tran, Peyman Benharash. Association of Frailty with Perioperative Outcomes Following Hepatic Resection: A National StudyJournal of the American Medical Directors Association 2022; 23(4): 684 doi: 10.1016/j.jamda.2022.02.004
37
Sahabjada Siddiqui, Rumana Ahmad, Mohsin Ali Khan, Shivbrat Upadhyay, Ishrat Husain, Anand Narain Srivastava. Cytostatic and Anti-tumor Potential of Ajwa Date Pulp against Human Hepatocellular Carcinoma HepG2 CellsScientific Reports 2019; 9(1) doi: 10.1038/s41598-018-36475-0
38
Qisthina Syifa Setiawan, Zuherman Rustam, Sri Hartini, Afifah Rofi Laeli, Ilsya Wirasati. Comparison of Naive Bayes and Decision Tree for Classifying Hepatocellular Carcinoma (HCC)2020 International Conference on Innovation and Intelligence for Informatics, Computing and Technologies (3ICT) 2020; : 1 doi: 10.1109/3ICT51146.2020.9312022
39
Chun-Ying Yan, Zuo-Jun Fu, Gui-Sheng Liu, Jiang Li, Chen-Xi Sun. Value of heat shock protein 90 combined with alpha-fetoprotein in early diagnosis of hepatocellular carcinomaWorld Chinese Journal of Digestology 2021; 29(21): 1215 doi: 10.11569/wcjd.v29.i21.1215
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
40
Archu Singh, Sadat Shafi, Tanya Upadhyay, Abul Kalam Najmi, Kanchan Kohli, Faheem Hyder Pottoo. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer TreatmentCurrent Topics in Medicinal Chemistry 2020; 20(20): 1839 doi: 10.2174/1568026620666200624161801
41
Huapeng Lin, Lingfeng Zeng, Jing Yang, Wei Hu, Ying Zhu. A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular CarcinomaFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.608260
42
AM Attallah, MS Albannan, MS El-Deen, K Farid, FM Khedr, KA Attallah, SO Abdallah. Diagnostic role of collagen-III and matrix metalloproteinase-1 for early detection of hepatocellular carcinomaBritish Journal of Biomedical Science 2020; 77(2): 58 doi: 10.1080/09674845.2019.1708534
43
Shichao Ding, Yanfeng Jin, Qingzhi Hao, Yanmeng Kang, Ruiping Ma. LncRNA BCYRN1/miR-490-3p/POU3F2, served as a ceRNA network, is connected with worse survival rate of hepatocellular carcinoma patients and promotes tumor cell growth and metastasisCancer Cell International 2020; 20(1) doi: 10.1186/s12935-019-1081-x
44
Ya Li, Qiuju Han, Huajun Zhao, Quanjuan Guo, Jian Zhang. Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular CarcinomaFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.597520
45
Diamantis I. Tsilimigras, Dimitrios Moris, J. Madison Hyer, Fabio Bagante, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Serum α-Fetoprotein Levels at Time of Recurrence Predict Post-Recurrence Outcomes Following Resection of Hepatocellular CarcinomaAnnals of Surgical Oncology 2021; 28(12): 7673 doi: 10.1245/s10434-021-09977-x
46
Shoufei Jiao, Guanqun Li, Dongxin Zhang, Yingchen Xu, Jie Liu, Guangming Li. Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysisInternational Journal of Surgery 2020; 80: 243 doi: 10.1016/j.ijsu.2020.05.008
47
Mohammed Mehadi Hassan Chowdhury, Christiancel Joseph J. Salazar, Md Nurunnabi. Recent advances in bionanomaterials for liver cancer diagnosis and treatmentBiomaterials Science 2021; 9(14): 4821 doi: 10.1039/D1BM00167A
48
Lilia Turcios, Eduardo Chacon, Catherine Garcia, Pedro Eman, Virgilius Cornea, Jieyun Jiang, Brett Spear, Chunming Liu, David S. Watt, Francesc Marti, Roberto Gedaly, Masaru Katoh. Autophagic flux modulation by Wnt/β-catenin pathway inhibition in hepatocellular carcinomaPLOS ONE 2019; 14(2): e0212538 doi: 10.1371/journal.pone.0212538
49
Yu Jin Kim, Nayeong Yuk, Hee Jeong Shin, Hye Jin Jung. The Natural Pigment Violacein Potentially Suppresses the Proliferation and Stemness of Hepatocellular Carcinoma Cells In VitroInternational Journal of Molecular Sciences 2021; 22(19): 10731 doi: 10.3390/ijms221910731
50
Satoyoshi Yamashita, Akira Kato, Toshitaka Akatsuka, Takashi Sawada, Tomohide Asai, Noriyuki Koyama, Kiwamu Okita. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinomaWorld Journal of Gastroenterology 2020; 26(13): 1463-1473 doi: 10.3748/wjg.v26.i13.1463
51
Spyridon Davakis, Michail Vailas, Alexandros Kozadinos, Panagiotis Sakarellos, Anastasia Karampa, Dimitrios Korkolis, Georgios Glantzounis, Alexandros Papalampros, Evangelos Felekouras. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach2022;  doi: 10.5772/intechopen.100231
52
Kwei-Yan Liu, Li-Ting Wang, Shih-Hsien Hsu. Modification of Epigenetic Histone Acetylation in Hepatocellular CarcinomaCancers 2018; 10(1): 8 doi: 10.3390/cancers10010008
53
Ling Yu, Zhenjie Wang, Zhuomao Mo, Binhua Zou, Yuanyuan Yang, Rui Sun, Wen Ma, Meng Yu, Shijun Zhang, Zhiqiang Yu. Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapyActa Pharmaceutica Sinica B 2021; 11(7): 2004 doi: 10.1016/j.apsb.2021.02.001
54
De-Ling Wu, Zhen-Dong Liao, Fang-Fang Chen, Wei Zhang, Ya-Shuo Ren, Can-Can Wang, Xiao-Xiao Chen, Dai-Yin Peng, Ling-Yi Kong. Benzophenones from Anemarrhena asphodeloides Bge. Exhibit Anticancer Activity in HepG2 Cells via the NF-κB Signaling PathwayMolecules 2019; 24(12): 2246 doi: 10.3390/molecules24122246
55
Badriya Baig, Sulafa Abdel Halim, Aaminah Farrukh, Yaser Greish, Amr Amin. Current status of nanomaterial-based treatment for hepatocellular carcinomaBiomedicine & Pharmacotherapy 2019; 116: 108852 doi: 10.1016/j.biopha.2019.108852
56
Xu Yao, Chen-ru Zhao, Hao Yin, KeWei Wang, Jian-jun Gao. Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cellsActa Pharmacologica Sinica 2020; 41(12): 1609 doi: 10.1038/s41401-020-0395-5
57
Cyriac A Philips, Sasidharan Rajesh, Dinu C Nair, Rizwan Ahamed, Jinsha K Abduljaleel, Philip Augustine. Hepatocellular Carcinoma in 2021: An Exhaustive UpdateCureus 2021;  doi: 10.7759/cureus.19274
58
Qianhui Chen, Xinyu Lu, Jiayi Xie, Na Ma, Weikang Xu, Zhiming Zhang, Xuan Huang, Hongyan Liu, Jinlin Hou, Xiaoyong Zhang, Wei Zhu. Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular CarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.813275
59
Badrinathan Sridharan, Naveen Devarajan, Rupal Jobanputra, Genekehal Siddaramana Gowd, Ida Mulayirikkal Anna, Anusha Ashokan, Shantikumar Nair, Manzoor Koyakutty. nCP:Fe Nanocontrast Agent for Magnetic Resonance Imaging-Based Early Detection of Liver Cirrhosis and Hepatocellular CarcinomaACS Applied Bio Materials 2021; 4(4): 3398 doi: 10.1021/acsabm.1c00001
60
Wen-Lung Su, Shih-Chang Chuang, Yu-Chu Wang, Lin-An Chen, Jian-Wei Huang, Wen-Tsan Chang, Shen-Nien Wang, King-Teh Lee, Chang-Shen Lin, Kung-Kai Kuo. Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinomaCancer Biomarkers 2020; 28(3): 341 doi: 10.3233/CBM-190507
61
Waleed El-Agawy, Sara Ahmed El-Ganainy, Magdy Abd Almawgoud Gad, Sherief Abd-Elsalam, Wessam Abd Alltaif Mostafa, Mohammed El-Sayed El-Shewi. Combined Transarterial Chemoembolization with Microwave Ablation versus Microwave Alone for Treatment of Medium Sized Hepatocellular CarcinomaCurrent Cancer Drug Targets 2022; 22(1): 77 doi: 10.2174/1568009622666220117094146
62
Feng Duan, Jing Yuan, Xuan Liu, Li Cui, Yan-Hua Bai, Xiao-Hui Li, Huang-Rong Xu, Chen-Yang Liu, Wei-Xing Yu. Feasibility of hyperspectral analysis for discrimination of rabbit liver VX2 tumorWorld Journal of Gastrointestinal Oncology 2019; 11(1): 1-8 doi: 10.4251/wjgo.v11.i1.1
63
Asmaa Elkhamesy, Manar Refaat, Mona S. O. Gouida, Salma S. Alrdahe, Magdy M. Youssef. Diminished CCl 4 ‐induced hepatocellular carcinoma, oxidative stress, and apoptosis by co‐administration of curcumin or selenium in mice Journal of Food Biochemistry 2022; 46(4) doi: 10.1111/jfbc.13845
64
Yuan Li, Zhong Li, Yunhao Jia, Bo Ding, Jinsong Yu. In Vitro Anti-hepatoma Activities of Notoginsenoside R1 Through Downregulation of Tumor Promoter miR-21Digestive Diseases and Sciences 2020; 65(5): 1364 doi: 10.1007/s10620-019-05856-4
65
Huijie Gao, Weibo Niu, Zhaobin He, Chao Gao, Cheng Peng, Jun Niu. SEC61G plays an oncogenic role in hepatocellular carcinoma cellsCell Cycle 2020; 19(23): 3348 doi: 10.1080/15384101.2020.1843816
66
Jianguo Li, Jin Zhou, Shuangshuang Kai, Can Wang, Daijun Wang, Jiying Jiang, Tao Huang. Network-Based Coexpression Analysis Identifies Functional and Prognostic Long Noncoding RNAs in Hepatocellular CarcinomaBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1371632
67
Jānis Vilmanis, Ieva Strēle, Arturs Ozoliņš, Edvīns Miklaševičs, Jānis Gardovskis. Epidemiology of Hepatocellular Carcinoma in Latvia from 1997 to 2017Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2022; 76(2): 246 doi: 10.2478/prolas-2022-0037
68
Luzie A. Doemel, Jessica G. Santana, Lynn J. Savic, Fabian M. Laage Gaupp, Tabea Borde, Alexandra Petukhova-Greenstein, Ahmet S. Kucukkaya, Isabel T. Schobert, Charlie A. Hamm, Bernhard Gebauer, John J. Walsh, Irvin Rexha, Fahmeed Hyder, MingDe Lin, David C. Madoff, Todd Schlachter, Julius Chapiro, Daniel Coman. Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor modelEuropean Radiology 2022; 32(4): 2437 doi: 10.1007/s00330-021-08337-3
69
Jing Yang, Xiujuan Zhang, Leilei Liu, Xin Yang, Qingfu Qian, Bin Du. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathwayLife Sciences 2021; 264: 118711 doi: 10.1016/j.lfs.2020.118711
70
Ki-Hyun Kim, Hyung-Hoon Oh, Dong-Jun Son, Ji-Yoon Hong, Young-Hoon Jeong, Jin-Seong Jung, Hyeong-Min Yu, Dae-Seong Myung, Sung-Bum Cho, Wan-Sik Lee, Jin-Woong Kim, Young-Eun Joo. Scapular metastasis of hepatocellular carcinoma presenting as acute bleeding and hematomaMedicine 2017; 96(46): e8736 doi: 10.1097/MD.0000000000008736
71
Jie Liu, Yue Wei, Tao Wang, Zhexiao Zhang, Hairong Huang, Chenfei Wang, Huawen Li, Qing Jia, Hongfu Wu, Tangbin Zou. The prognostic significance of long non-coding RNAs in hepatocellular carcinoma: An updated meta-analysisThe International Journal of Biological Markers 2020; 35(4): 3 doi: 10.1177/1724600820965579
72
Linhe Wang, Xiangchao Ling, Caihui Zhu, Zhiheng Zhang, Ziming Wang, Shanzhou Huang, Yunhua Tang, Shujiao He, Zhiyong Guo, Xiaoshun He. Upregulated Seizure-Related 6 Homolog-Like 2 Is a Prognostic Predictor of Hepatocellular CarcinomaDisease Markers 2020; 2020: 1 doi: 10.1155/2020/7318703
73
Dimitrios Moris, Brian I. Shaw, Lisa McElroy, Andrew S. Barbas. Using Hepatocellular Carcinoma Tumor Burden Score to Stratify Prognosis after Liver TransplantationCancers 2020; 12(11): 3372 doi: 10.3390/cancers12113372
74
Rusdina Bte Ladju, Zulvikar Syambani Ulhaq, Gita Vita Soraya. Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinomaWorld Journal of Gastroenterology 2022; 28(2): 176-187 doi: 10.3748/wjg.v28.i2.176
75
Luzie A. Doemel, Julius Chapiro, Fabian Laage Gaupp, Lynn Jeanette Savic, Ahmet S. Kucukkaya, Alexandra Petukhova, Jonathan Tefera, Tal Zeevi, MingDe Lin, Todd Schlachter, Ariel Jaffe, Mario Strazzabosco, Timil Patel, Stacey M. Stein. Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRIEuropean Radiology 2021; 31(5): 2737 doi: 10.1007/s00330-020-07381-9
76
Akira Hokama, Shingo Arakaki, Shinichiro Ishino, Yutaka Nakagawa, Souhei Tabata, Daiki Agarie, Satoshi Kuwae, Ryuta Zukeyama, Tatsuji Maeshiro, Yuma Tsuruta, Akiko Matsuzaki, Naoki Wada, Mitsuhisa Takatsuki, Jiro Fujita. Hepatocellular Carcinoma in a Patient With Crohn’s DiseaseCureus 2021;  doi: 10.7759/cureus.16570
77
Shen Shen, Yanfang Wang. Expression and Prognostic Role of E2F2 in Hepatocellular CarcinomaInternational Journal of General Medicine 2021; : 8463 doi: 10.2147/IJGM.S334033
78
Zheng Yu, Rongchang Wang, Fan Chen, Jianru Wang, Xiaohui Huang. Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation SequencingDigestive Diseases and Sciences 2018; 63(4): 945 doi: 10.1007/s10620-018-4961-3
79
Wei Zhang, Zhong Chen, Chengjun Xue, Yao Zhang, Lipei Wu, Jichao Zhu, Shihai Xuan, Jiale Tian, Zhi Pang. The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular CarcinomaFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.740029
80
Kaio Murilo Monteiro Espíndola, Roseane Guimarães Ferreira, Luis Eduardo Mosquera Narvaez, Amanda Caroline Rocha Silva Rosario, Agnes Hanna Machado da Silva, Ana Gabrielle Bispo Silva, Ana Paula Oliveira Vieira, Marta Chagas Monteiro. Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in HepatocarcinomaFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00541
81
Fanbo Qin, Junyong Zhang, Jianping Gong, Wenfeng Zhang, Shibiao Wan. Identification and Validation of a Prognostic Model Based on Three Autophagy-Related Genes in Hepatocellular CarcinomaBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/5564040
82
Wenyue Zhang, Juan Huang, Yao Tang, Yixuan Yang, Huaidong Hu. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathwayAnnals of Hepatology 2020; 19(4): 411 doi: 10.1016/j.aohep.2020.03.005
83
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, Vasiliki E. Georgakopoulou, Panagiotis Sarantis, Efstathios A. Antoniou, Michalis V. Karamouzis, Afroditi Nonni, Dimitrios Schizas, Evangelos Diamantis, Evangelos Koustas, Paraskevi Farmaki, Athanasios Syllaios, Alexandros Patsouras, Konstantinos Kontzoglou, Nikolaos Trakas, Dimitrios Dimitroulis. Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future OpportunitiesJournal of Personalized Medicine 2021; 11(3): 223 doi: 10.3390/jpm11030223
84
Yang Liu, Heng Yang, Qiang Guo, Tingting Liu, Yong Jiang, Mingbo Zhao, Kewu Zeng, Pengfei Tu. Cucurbitacin E Inhibits Huh7 Hepatoma Carcinoma Cell Proliferation and Metastasis via Suppressing MAPKs and JAK/STAT3 PathwaysMolecules 2020; 25(3): 560 doi: 10.3390/molecules25030560
85
Dong-Jun Son, Ji-Yun Hong, Ki-Hyun Kim, Young-Hoon Jeong, Dae-Seong Myung, Sung-Bum Cho, Wan-Sik Lee, Yang-Jun Kang, Jin-Woong Kim, Young-Eun Joo. Liver abscess caused by Clostridium haemolyticum infection after transarterial chemoembolization for hepatocellular carcinomaMedicine 2018; 97(19): e0688 doi: 10.1097/MD.0000000000010688
86
Yanting Xie, Yizhou Wang, Renyan Gong, Jianbo Lin, Xifeng Li, Junyong Ma, Lei Huo. SNHG7 Facilitates Hepatocellular Carcinoma Occurrence by Sequestering miR-9-5p to Upregulate CNNM1 ExpressionCancer Biotherapy and Radiopharmaceuticals 2020; 35(10): 731 doi: 10.1089/cbr.2019.2996
87
Xue-Qin Li, Xing Wang, Da-Wei Zhao, Jun Sun, Jiao-Jiao Liu, Dong-Dong Lin, Guang Yang, Hui Liu, Zhen-Ying Xia, Cui-Yu Jia, Hong-Jun Li. Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinomaWorld Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01996-4
88
Teresa Marzia Rogger, Andrea Michielan, Sandro Sferrazza, Cecilia Pravadelli, Luisa Moser, Flora Agugiaro, Giovanni Vettori, Sonia Seligmann, Elettra Merola, Marcello Maida, Francesco Antonio Ciarleglio, Alberto Brolese, Giovanni de Pretis. Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literatureWorld Journal of Gastroenterology 2020; 26(35): 5375-5386 doi: 10.3748/wjg.v26.i35.5375
89
Mohammad Imran, Gowru Srivani, Ganji Seeta Rama Raju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 32022; : 197 doi: 10.1016/B978-0-323-99283-1.00026-4
90
María V Espelt, María L Bacigalupo, Pablo Carabias, María F Troncoso. MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinomaWorld Journal of Hepatology 2019; 11(4): 344-358 doi: 10.4254/wjh.v11.i4.344
91
Chao Chen, Yaohui Wang, Guodong Li, Lichao Xu, Ying Wang, Haozhe Huang, Biao Wang, Wentao Li, Xinhong He. Feasibility of CT-CT fusion imaging for evaluation of the cryoablation margins in visible hepatocellular carcinoma on unenhanced CT images: Initial experienceJournal of Interventional Medicine 2019; 2(2): 60 doi: 10.1016/j.jimed.2019.09.003
92
Danni Li, Shaogang Liu, Jiahao Zhu, Liqun Shen, Qi ying Zhang, Hua Zhu. Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular carcinomaBMC Pharmacology and Toxicology 2021; 22(1) doi: 10.1186/s40360-020-00461-y
93
Wan Sun, Changchang Hu, Tianyu Wang, Juan Wang, Jieping Zhang, Furong Gao, Qingjian Ou, Haibin Tian, Caixia Jin, Jingying Xu, Jingfa Zhang, Guo-Tong Xu, Lixia Lu. Glia Maturation Factor Beta as a Novel Biomarker and Therapeutic Target for Hepatocellular CarcinomaFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.744331
94
Pedro Molina-Sánchez, Amaia Lujambio. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 333 doi: 10.1007/978-3-030-21540-8_16
95
Wafaa Mansour, Manal Kamel, Emad Elzayat, Shimaa Atta, Dalia Mahmood, Hanaa Abd El Fattah El Sayed, Taghreed Hussein, Sara Saber. Therapeutic Role of Bone Marrow-Derived Mesenchymal Stem Cells in Controlling Prognosis of Hepatocellular Carcinoma in a Murine ModelExperimental and Clinical Transplantation 2022; 20(1): 62 doi: 10.6002/ect.2020.0495
96
Hua-Ming Cheng, Toshihiro Tanaka, Hideyuki Nishiofuku, Yuto Chanoki, Katsutoshi Horiuchi, Tetsuya Masada, Shota Tatsumoto, Takeshi Matsumoto, Nagaaki Marugami, Kimihiko Kichikawa. Safety and Prognosis of Transarterial Chemoembolization for Octogenarians with Hepatocellular CarcinomaCardioVascular and Interventional Radiology 2019; 42(10): 1413 doi: 10.1007/s00270-019-02290-x
97
Abhiram Natu, Anjali Singh, Sanjay Gupta. Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalitiesWorld Journal of Hepatology 2021; 13(11): 1568-1583 doi: 10.4254/wjh.v13.i11.1568
98
Zuhua Li, Ye Zhou, Guohua Yang, Siying He, Xueping Qiu, Lei Zhang, Qianyun Deng, Fang Zheng. Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinomaClinica Chimica Acta 2019; 492: 37 doi: 10.1016/j.cca.2019.02.001
99
Yong-Guang Wei, Cheng-Kun Yang, Zhong-Liu Wei, Xi-Wen Liao, Yong-Fei He, Xin Zhou, Hua-Sheng Huang, Chen-Lu Lan, Chuang-Ye Han, Tao Peng. High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular CarcinomaInternational Journal of General Medicine 2022; : 609 doi: 10.2147/IJGM.S344858
100
Divya Niveditha, Sudeshna Mukherjee, Syamantak Majumder, Rajdeep Chowdhury, Shibasish Chowdhury, Inanc Birol. A global transcriptomic pipeline decoding core network of genes involved in stages leading to acquisition of drug-resistance to cisplatin in osteosarcoma cellsBioinformatics 2019; 35(10): 1701 doi: 10.1093/bioinformatics/bty868
101
Krzysztof Bartnik, Joanna Podgórska, Grzegorz Rosiak, Krzysztof Korzeniowski, Jakub Giziński, Michał Sajdek, Tadeusz Wróblewski, Krzysztof Zieniewicz, Paweł Nyckowski, Olgierd Rowiński. Performance of initial LI-RADS 2018 treatment response in predicting survival of patients with hepatocellular carcinoma following TACE: a retrospective, single-center cohort studyJournal of Cancer Research and Clinical Oncology 2021; 147(12): 3673 doi: 10.1007/s00432-021-03603-9
102
HepG2 Attenuation Induced by RNase A Modulates Gene Profiling and Immunophenotypic Characterization of Some Immune Cells Operating in Cancer Vaccine Journal of Cancer Research Updates 2018; 7(1): 27 doi: 10.6000/1929-2279.2018.07.01.3
103
Han-Yu Jiang, Jie Chen, Chun-Chao Xia, Li-Kun Cao, Ting Duan, Bin Song. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosisWorld Journal of Gastroenterology 2018; 24(22): 2348-2362 doi: 10.3748/wjg.v24.i22.2348
104
Bin Sun, Dong Yang, Hongjiu Dai, Xiuyun Liu, Ru Jia, Xiaoyue Cui, Wenxuan Li, Changchun Cai, Jianming Xu, Xudong Zhao. Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T CellsCancer Immunology Research 2019; 7(11): 1813 doi: 10.1158/2326-6066.CIR-19-0026
105
Yan-Li Zhu, Zhen-Qiang Wang, Xiang-Ming Wang. Relationship between MRI delayed enhancement of primary hepatocellular carcinoma and distribution of different fibrous components in pathological tissuesWorld Chinese Journal of Digestology 2019; 27(19): 1225 doi: 10.11569/wcjd.v27.i19.1225
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
106
Wenbiao Chen, Donge Tang, Minglin Ou, Yong Dai. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated GenesDNA and Cell Biology 2020; 39(4): 499 doi: 10.1089/dna.2019.5099
107
Ronik S. Bhangoo, Trey C. Mullikin, Jonathan B. Ashman, Tiffany W. Cheng, Michael A. Golafshar, Todd A. DeWees, Jedediah E. Johnson, Satomi Shiraishi, Wei Liu, Yanle Hu, Kenneth W. Merrell, Michael G. Haddock, Sunil Krishnan, William G. Rule, Terence T. Sio, Christopher L. Hallemeier. Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical ExperienceAdvances in Radiation Oncology 2021; 6(4): 100675 doi: 10.1016/j.adro.2021.100675
108
Hantao Xue, Liya Qin, Longxiang Zhang, Xiaocheng Li, Fei Wu, Weiyu Wang, Chen Wang, Wenbin Diao, Bin Jiang, Bo Lian, Jingliang Wu, Jingkun Bai, Tongyi Sun, Chunling Zhao, Meihua Qu, Wenjing Yu, Yubing Wang, Zhiqin Gao. Preparation of docetaxel‑loaded, glycyrrhetinic acid‑modified nanoparticles and their liver‑targeting and antitumor activityExperimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10578
109
Olga Y. Burenina, Natalia L. Lazarevich, Inna F. Kustova, Daria A. Shavochkina, Ekaterina A. Moroz, Nikolay E. Kudashkin, Yuriy I. Patyutko, Alexey V. Metelin, Eduard F. Kim, Dmitry A. Skvortsov, Timofei S. Zatsepin, Maria P. Rubtsova, Olga A. Dontsova. Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumorsJournal of Cancer Research and Clinical Oncology 2021; 147(1): 49 doi: 10.1007/s00432-020-03378-5
110
Tian Zuo, Zuo Zhang, Peng Jiang, Rui Zhang, Danni Ni, Yuan Yuan, Shaopeng Zhang. Characterization of chikusetsusaponin IV and V induced apoptosis in HepG2 cancer cellsMolecular Biology Reports 2022;  doi: 10.1007/s11033-022-07259-7
111
Upkar S. Gill, Patrick T. F. Kennedy. The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeuticsJournal of Viral Hepatitis 2018;  doi: 10.1111/jvh.13040
112
Jia-jia Lv, Wen-ting Song, Xin-min Li, Jian-mei Gao, Ze-li Yuan. Synthesis of a New Phenyl Chlormethine-Quinazoline Derivative, a Potential Anti-Cancer Agent, Induced Apoptosis in Hepatocellular Carcinoma Through Mediating Sirt1/Caspase 3 Signaling PathwayFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00911
113
A.N. Katrich, A.N. Petrovskiy, N.A. Katrich, V.A. Porkhanov. Ultrasound in a differentiated treatment approach for liver diseasesKhirurgiya. Zhurnal im. N.I. Pirogova 2021; (12): 34 doi: 10.17116/hirurgia202112134
114
M A Osadchuk, A A Svistunov, E D Mironova, I N Vasil’eva, N V Kireeva. Diseases of biliary tract in the context of association with oncological diseases of the digestive systemTerapevticheskii arkhiv 2019; 91(12): 98 doi: 10.26442/00403660.2019.12.000455
115
Fei Chen, Fei Wang, Si Sun, Mei Zhu, Zheng Liu. Size measurements of hepatocellular carcinoma: comparisons between contrast and two-dimensional ultrasoundBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01535-1
116
L.S.S. Srivani Nagam, Ramakrishna Vadde, Rajeswari Jinka. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 125 doi: 10.1016/B978-0-323-98806-3.00013-1
117
Hamzah Adwan, Thomas J. Vogl, Ümniye Balaban, Nour-Eldin Abdelrehim Nour-Eldin. Percutaneous Thermal Ablation Therapy of Hepatocellular Carcinoma (HCC): Microwave Ablation (MWA) versus Laser-Induced Thermotherapy (LITT)Diagnostics 2022; 12(3): 564 doi: 10.3390/diagnostics12030564
118
Ravikiran Tekupalli, Santosh Anand, Sowbhagya Ramachandregowda, Anupama Sindhghatta Kariyappa. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 22022; : 195 doi: 10.1016/B978-0-323-98807-0.00019-3
119
Sen Wang, Geng Chen, Xiao Lin, Xiaohua Xing, Zhixiong Cai, Xiaolong Liu, Jingfeng Liu. Role of exosomes in hepatocellular carcinoma cell mobility alterationOncology Letters 2017;  doi: 10.3892/ol.2017.7257
120
Dimitrios Moris, Diamantis I. Tsilimigras, Ioannis D. Kostakis, Ioannis Ntanasis-Stathopoulos, Kevin N. Shah, Evangelos Felekouras, Timothy M. Pawlik. Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysisEuropean Journal of Surgical Oncology 2018; 44(7): 927 doi: 10.1016/j.ejso.2018.04.018
121
Omaima Mohamed Ali, Hussein Ahmed El Amin, Yousry Lotfy Sharkawy, Adnan Ahmed Mohamed Ali, Emad Farah Mohammed Kholef, Wael Abd Elgwad Elsewify. <p>Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma</p>International Journal of General Medicine 2020; : 193 doi: 10.2147/IJGM.S253622
122
Divya R, Radha P. An Optimized HCC Recurrence Prediction Using APO Algorithm Multiple Time Series Clinical Liver Cancer DatasetJournal of Medical Systems 2019; 43(7) doi: 10.1007/s10916-019-1265-x
123
Roseane Guimarães Ferreira, Magda Vieira Cardoso, Karine Maria de Souza Furtado, Kaio Murilo Monteiro Espíndola, Ruanderson Pereira Amorim, Marta Chagas Monteiro. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinomaTranslational Research 2019; 204: 51 doi: 10.1016/j.trsl.2018.09.001
124
I. Mirón Fernández, F.J. León Díaz, J. Sánchez Segura, B. Sánchez Pérez, J.A. Pérez Daga, J.L. Fernández Aguilar, M.C. Montiel Casado, J. Santoyo Santoyo. Comparison of 3 Explant-Based Prognostic Models as Predictors of Hepatocellular Carcinoma Recurrence After Liver Transplantation: Analysis of Our ExperienceTransplantation Proceedings 2019; 51(1): 80 doi: 10.1016/j.transproceed.2018.03.132
125
Jacek Hawiger, Jozef Zienkiewicz. Decoding inflammation, its causes, genomic responses, and emerging countermeasuresScandinavian Journal of Immunology 2019; 90(6) doi: 10.1111/sji.12812
126
Weibo Du, Wenbiao Chen, Zheyue Shu, Dairong Xiang, Kefan Bi, Yingfeng Lu, Xujun Zhang, Lanjuan Li, Hongyan Diao. Identification of prognostic biomarkers of hepatocellular carcinoma via long noncoding RNA expression and copy number alterationsEpigenomics 2020; 12(15): 1303 doi: 10.2217/epi-2019-0385
127
Lianxiang Luo, Xinyue Yao, Jing Xiang, Fangfang Huang, Hui Luo. Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinomaScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14554-7
128
Yanling Bai, Zhigang Zheng, Mingmei Du, Hongwu Yao, Yunxi Liu, Jijiang Suo. Bloodstream Infection and Its Clinical Characteristics and Relevant Factors Associated with Interventional Therapy in a Large Tertiary Hospital: A Six Years Surveillance StudyBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/8190475
129
Said A. Al-Busafi, Khalid AlNaamani. Liver Cancer in the Middle East2021; : 259 doi: 10.1007/978-3-030-78737-0_17
130
Xiancheng Ou, Bikash Karmakar, Nasser S. Awwad, Hala A. Ibrahium, Hosam-Eldin Hussein Osman, Attalla F. El-kott, Mohamed M. Abdel-Daim. Au nanoparticles adorned chitosan-modified magnetic nanocomposite: An investigation towards its antioxidant and anti-hepatocarcinoma activity in vitroInorganic Chemistry Communications 2022; 137: 109221 doi: 10.1016/j.inoche.2022.109221
131
Minoru Yamakado, Takayuki Tanaka, Kenji Nagao, Akira Imaizumi, Michiharu Komatsu, Takashi Daimon, Hiroshi Miyano, Mizuki Tani, Akiko Toda, Hiroshi Yamamoto, Katsuhisa Horimoto, Yuko Ishizaka. Plasma amino acid profile associated with fatty liver disease and co-occurrence of metabolic risk factorsScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14974-w
132
Yuming Jia, Shengchao Li, Meng Zhang, Zhilei Zhang, Chao Wang, Chong Zhang, Wuhan Yang, Li Peng, Zhuo Xu. Circ_LDLR Knockdown Suppresses Progression of Hepatocellular Carcinoma via Modulating miR-7/RNF38 AxisCancer Management and Research 2021; : 337 doi: 10.2147/CMAR.S275003
133
Matteo Renzulli, Francesco Tovoli, Alfredo Clemente, Anna Maria Ierardi, Irene Pettinari, Giuliano Peta, Giovanni Marasco, Davide Festi, Fabio Piscaglia, Salvatore Cappabianca, Gianpaolo Carrafiello, Rita Golfieri. Ablation for hepatocellular carcinoma: beyond the standard indicationsMedical Oncology 2020; 37(4) doi: 10.1007/s12032-020-01348-y
134
Soo-Hyeon Kim, Byung-Joon Seung, Seung-Hee Cho, Ha-Young Lim, Min-Kyung Bae, Jung-Hyang Sur. Arginase-1 and P-glycoprotein are downregulated in canine hepatocellular carcinomaJournal of Veterinary Science 2021; 22(5) doi: 10.4142/jvs.2021.22.e61
135
Juan Wang, Pengpeng Zhang, Juan Liao, Yan Zhu, Xiaoli Liu, Hong Tang. Association of α-fetoprotein levels with liver stiffness measurement in outpatients with chronic hepatitis BBioscience Reports 2021; 41(1) doi: 10.1042/BSR20203048
136
Armeen Mahvash, Steven Chartier, Mark Turco, Paula Habib, Steven Griffith, Scott Brown, S. Cheenu Kappadath. A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) studyBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02204-1
137
Olorunseun O Ogunwobi, Trisheena Harricharran, Jeannette Huaman, Anna Galuza, Oluwatoyin Odumuwagun, Yin Tan, Grace X Ma, Minhhuyen T Nguyen. Mechanisms of hepatocellular carcinoma progressionWorld Journal of Gastroenterology 2019; 25(19): 2279-2293 doi: 10.3748/wjg.v25.i19.2279
138
Shuangmei Zhao, Yongqi Zhen, Leilei Fu, Feng Gao, Xianli Zhou, Shuai Huang, Lan Zhang. Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cellsBioorganic & Medicinal Chemistry Letters 2019; 29(19): 126623 doi: 10.1016/j.bmcl.2019.126623
139
Ying Yang, Feng-Ping Wu, Wen-Jun Wang, Juan-Juan Shi, Ya-Ping Li, Xin Zhang, Shuang-Suo Dang. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest ChinaWorld Journal of Gastroenterology 2019; 25(44): 6551-6560 doi: 10.3748/wjg.v25.i44.6551
140
M. Ghosn, H. Derbel, R. Kharrat, N. Oubaya, S. Mulé, J. Chalaye, H. Regnault, G. Amaddeo, E. Itti, A. Luciani, H. Kobeiter, V. Tacher. Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteriaDiagnostic and Interventional Imaging 2021; 102(1): 35 doi: 10.1016/j.diii.2020.09.004
141
Maria Corina Plaz Torres, Quirino Lai, Fabio Piscaglia, Eugenio Caturelli, Giuseppe Cabibbo, Elisabetta Biasini, Filippo Pelizzaro, Fabio Marra, Franco Trevisani, Edoardo G. Giannini. Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life SettingJournal of Clinical Medicine 2021; 10(15): 3201 doi: 10.3390/jcm10153201
142
Chintapanti Swetha, Bala Prabhakar Girish. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 73 doi: 10.1016/B978-0-323-98806-3.00016-7
143
Arno Kornberg, Helmut Friess. 18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approachesTherapeutic Advances in Gastroenterology 2019; 12: 175628481983620 doi: 10.1177/1756284819836205